Fund moves

Bio-Rad Laboratories (BIO): Bridgewater Associates opened a new position $469K

Bridgewater Associates opened a new position in Bio-Rad Laboratories, per its Q1 2026 13F.

1,684
Shares reported
0.00%
Disclosed portfolio weight
$469K
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

What stands out in this filing

  • A new position in Q1 2026: 1,684 shares, none in the manager's Q4 2025 filing.
  • 5 other tracked managers reported the same kind of change for Q1 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 21, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On April 21, 2026, at the annual meeting of stockholders (the “Annual Meeting”) of Bio-Rad Laboratories, Inc. (the “Company”), as further described in Item 5.07 below, the Company’s stockholders approved the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan (the “Plan”).”
  2. Apr 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. May 11, 2026InsiderOfficer sold ~$136K of BIO shares in the open market

What came next

  1. Jul 31, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results (and 1 more item)“On July 31, 2026, Bio-Rad Laboratories, Inc. (the “ Company ") initiated a strategy-driven restructuring plan as part of our ongoing program to improve operating performance and strengthen the Company’s competitive position.”
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Bio-Rad Laboratories

For Bio-Rad Laboratories, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BIO page.

How this filing works

Explore the data

Common questions

What does this filing report about Bio-Rad Laboratories (BIO) stock?

Bridgewater Associates opened a new position in Bio-Rad Laboratories, per its Q1 2026 13F. 1,684 shares reported, 0.00% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: May 15, 2026.

What stands out in this filing?

A new position in Q1 2026: 1,684 shares, none in the manager's Q4 2025 filing. 5 other tracked managers reported the same kind of change for Q1 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Bio-Rad Laboratories recently?

For Bio-Rad Laboratories, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BIO page.

Does this mean BIO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Bio-Rad Laboratories

Everything OQRO holds on this company is on its BIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data